It’s Not The Nicotine Itself, It’s The Cigarette …
There may be a very good reason why coffee and cigarettes often seem to go hand in hand.
A Kansas State University psychology professor’s research suggests that nicotine’s power may be in how it enhances other experiences. For a smoker who enjoys drinking coffee, the nicotine may make a cup of joe even better.
And that may explain why smoking is so hard to quit.
“People have very regimented things they do when they smoke,” said Matthew Palmatier, assistant professor of psychology at K-State. “If you think about where people smoke or who they smoke with, you realize that it occurs in very specific places, often with a specific group of people. Maybe it’s a reason why nicotine is so addictive — if you get used to having that extra satisfaction from things you normally enjoy, not having nicotine could reduce the enjoyment in a given activity.
“People may not be smoking to obtain a pleasurable drug state. They may be smoking in order to regulate their mood, and that effect could make nicotine more addictive than other drugs.”
Palmatier said much previous research on nicotine addiction has looked at the drug itself rather than the other factors he is studying.
“The approach we’re taking is out of left field,” he said. “But it seems to be one of the best explanations as to why people smoke.”
Palmatier has a grant from the National Institute on Drug Abuse to understand how this phenomenon can be used to better design tobacco addiction treatments, usually offered in patches and pills. He began psychological research in addiction as a graduate student and later began researching the reinforcing effects of nicotine.
“The big picture is trying to figure out why people smoke,” Palmatier said. “There are a lot of health risks, and the majority of smokers already know what they are. They want to quit but can’t. It’s not because nicotine is a potent drug; it doesn’t induce significant amounts of pleasure or euphoria. Yet, it’s just as difficult if not more difficult to quit than other drugs.”
At K-State, Palmatier studies rats that are allowed to self-administer nicotine by pushing a lever. The main source of light in their testing environment shuts off when the rats earn a dose of nicotine. After about a minute, the light comes back on to signal that more nicotine is available.
By manipulating this signal, Palmatier and his colleagues found that the rats weren’t really that interested in nicotine by itself.
“We figured out that what the rats really liked was turning the light off,” Palmatier said. “They still self-administered the nicotine, but they took more of the drug when it was associated with a reinforcing light.”
Palmatier and colleagues published a paper on their research in the August issue of Neuropsychopharmacology.
Palmatier has begun looking at how rats respond to sweet tastes after having nicotine. He said preliminary results show that nicotine has comparable effects on sweet tastes. That is, rats respond more for sugar-water solutions after getting nicotine.
“The taste aspect is really important because we can actually figure out how nicotine is increasing the subjects’ behavior,” Palmatier said. “If it makes a reward more pleasurable, then it may increase the palatability of a sweet taste.”
Palmatier said that a future phase of research would be determining whether nicotine can make unpleasant experiences more tolerable, helping explain why lighting up after a bad day at work can be tempting.
Neuropsychopharmacology. 2008 Aug;33(9):2139-47. Epub 2007 Nov 28.
Metabotropic glutamate 5 receptor (mGluR5) antagonists decrease nicotine seeking, but do not affect the reinforcement enhancing effects of nicotine.
Palmatier MI, Liu X, Donny EC, Caggiula AR, Sved AF.
Department of Psychology, University of Pittsburgh, Pittsburgh, PA, USA. email@example.com
Nicotine self-administration models typically evaluate the effects of smoking cessation aides on ‘primary reinforcement’ engendered by nicotine. However, the more recently described reinforcement enhancing effects of the drug are not always included in experimental analyses of potential therapeutics. We evaluated the effects of pretreatment with noncompetitive antagonists of the metabotropic glutamate 5 receptor (mGluR5) on each reinforcement-related effect of nicotine using a model in which a reinforcing visual stimulus (VS) and nicotine infusions were concurrently available. Five groups (2-lever, VS-only, NIC+VS, NIC-only, or SAL-only) were instrumented for self-administration. The 2-lever group could earn a nicotine infusion (0.06 mg/kg per infusion free base) for meeting the schedule on one lever (eg right), or VS for meeting the schedule on the other lever (eg left). The VS-only group could earn VS or saline under similar contingencies. Remaining rats could press one lever to earn both reinforcers (NIC+VS), nicotine infusions (NIC-only), or saline infusions (SAL-only); the other lever was ‘inactive’. Responding on the VS lever in the 2-lever group was greater than that of the VS-only group, reflecting the reinforcement-enhancing effect of nicotine. Pretreatment with 2-methyl-6-(phenylethynyl)-pyridine (MPEP) or 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) decreased nicotine intake as well as the enhanced responding for the concurrently available VS. In follow-up studies, replacing nicotine via experimenter-administered infusions sustained the drugs reinforcement enhancing effect; neither MPEP nor MTEP decreased the enhancing effects of nicotine. These findings are consistent with other studies suggesting that mGlu5 receptors mediate nicotine seeking, but do not alter the reinforcement enhancing effects of nicotine.